{"title":"Future aspects of BMIPP.","authors":"N Tamaki, K Morita, E Tsukamoto, Y Kawai","doi":"10.1023/a:1006109022417","DOIUrl":null,"url":null,"abstract":"<p><p>Iodinated fatty acid compounds have an important role in early detection of myocardial abnormalities and provide insights into pathological states in the heart. Among them, 15-(p-iodophenyl)-3R,S-methyl pentadecanoic acid (BMIPP) has been most widely used providing excellent images of the left ventricular myocardium due to high myocardial uptake and long retention. The previous chapters have focused on the basic characters and clinical applications of this compound. However, the precise mechanisms of myocardial kinetics should be further investigated under various conditions. Most of the studies showed reduced BMIPP uptake relative to perfusion in a variety of myocardial disorders, whereas an increase in BMIPP uptake relative to perfusion is often reported. The potential mechanisms of such conflicting results are discussed, but basic studies should be performed to clarify such results in detail. There are a number of clinical values of this compound. Since alteration of fatty acid is observed in the repetitive ischemia, BMIPP can be used for detecting severe ischemic episodes. The concept of 'ischemic memory' imaging can be applied for patients with unstable or vasospastic angina at rest and for those with acute myocardial infarction with successful revascularization to identify the risk area. The discordant decrease in BMIPP uptake relative to perfusion is often seen in ischemic but viable myocardium, and therefore, the combined imaging of BMIPP and perfusion can be used for assessment of tissue viability. Furthermore, abnormal BMIPP uptake is most often observed in hypertrophic cardiomyopathy, and thus, this compound can be used for an early detection and differential diagnosis of the cardiomyopathy. Although BMIPP imaging seems to be quite promising in many fields, the number of patient data remain limited. In this respect, a multicenter study with a vast majority of patients is warranted to confirm these important values of BMIPP. In addition, this attractive tracer should be available all over the world to confirm its clinical value in the near future.</p>","PeriodicalId":77179,"journal":{"name":"International journal of cardiac imaging","volume":"15 1","pages":"79-89"},"PeriodicalIF":0.0000,"publicationDate":"1999-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1023/a:1006109022417","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cardiac imaging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1023/a:1006109022417","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8
Abstract
Iodinated fatty acid compounds have an important role in early detection of myocardial abnormalities and provide insights into pathological states in the heart. Among them, 15-(p-iodophenyl)-3R,S-methyl pentadecanoic acid (BMIPP) has been most widely used providing excellent images of the left ventricular myocardium due to high myocardial uptake and long retention. The previous chapters have focused on the basic characters and clinical applications of this compound. However, the precise mechanisms of myocardial kinetics should be further investigated under various conditions. Most of the studies showed reduced BMIPP uptake relative to perfusion in a variety of myocardial disorders, whereas an increase in BMIPP uptake relative to perfusion is often reported. The potential mechanisms of such conflicting results are discussed, but basic studies should be performed to clarify such results in detail. There are a number of clinical values of this compound. Since alteration of fatty acid is observed in the repetitive ischemia, BMIPP can be used for detecting severe ischemic episodes. The concept of 'ischemic memory' imaging can be applied for patients with unstable or vasospastic angina at rest and for those with acute myocardial infarction with successful revascularization to identify the risk area. The discordant decrease in BMIPP uptake relative to perfusion is often seen in ischemic but viable myocardium, and therefore, the combined imaging of BMIPP and perfusion can be used for assessment of tissue viability. Furthermore, abnormal BMIPP uptake is most often observed in hypertrophic cardiomyopathy, and thus, this compound can be used for an early detection and differential diagnosis of the cardiomyopathy. Although BMIPP imaging seems to be quite promising in many fields, the number of patient data remain limited. In this respect, a multicenter study with a vast majority of patients is warranted to confirm these important values of BMIPP. In addition, this attractive tracer should be available all over the world to confirm its clinical value in the near future.
碘化脂肪酸化合物在早期检测心肌异常和了解心脏病理状态方面具有重要作用。其中,15-(对碘苯基)- 3r, s -甲基戊酸(BMIPP)由于心肌摄取高、滞留时间长,应用最广泛,提供了良好的左心室心肌图像。前几章重点介绍了该化合物的基本特征和临床应用。然而,在各种条件下,心肌动力学的确切机制有待进一步研究。大多数研究显示,在各种心肌疾病中,BMIPP摄取相对于灌注减少,而BMIPP摄取相对于灌注增加也经常被报道。讨论了这些相互矛盾的结果的潜在机制,但需要进行基础研究以详细阐明这些结果。这种化合物有许多临床价值。由于在重复缺血中可以观察到脂肪酸的改变,BMIPP可以用于检测严重的缺血发作。“缺血记忆”成像的概念可以应用于不稳定或血管痉挛性心绞痛患者,以及那些成功重建血管的急性心肌梗死患者,以识别危险区域。BMIPP摄取相对于灌注的不一致下降常见于缺血但存活的心肌,因此,BMIPP与灌注的联合成像可用于评估组织活力。此外,在肥厚性心肌病中最常观察到异常的BMIPP摄取,因此,该化合物可用于心肌病的早期检测和鉴别诊断。尽管BMIPP成像在许多领域似乎很有前景,但患者数据的数量仍然有限。在这方面,有必要对绝大多数患者进行多中心研究,以证实BMIPP的这些重要价值。此外,在不久的将来,这种有吸引力的示踪剂应该可以在全球范围内使用,以证实其临床价值。